Cytoplasmic p21(CIP1/WAF1), ERK1/2 activation, and cytoskeletal remodeling are associated with the senescence-like phenotype after airborne particulate matter (PM(10)) exposure in lung cells

Toxicol Lett. 2014 Feb 10;225(1):12-9. doi: 10.1016/j.toxlet.2013.11.018. Epub 2013 Nov 26.

Abstract

The exposure to particulate matter with a mean aerodynamic diameter ≤10 μm (PM10) from urban zones is considered to be a risk factor in the development of cancer. The aim of this work was to determine if PM10 exposure induces factors related to the acquisition of a neoplastic phenotype, such as cytoskeletal remodeling, changes in the subcellular localization of p21(CIP1/WAF1), an increase in β-galactosidase activity and changes in cell cycle. To test our hypothesis, PM10 from an industrial zone (IZ) and a commercial zone (CZ) were collected, and human adenocarcinoma lung cell cultures (A549) were exposed to a sublethal PM10 concentration (10 μg/cm(2)) for 24 h and 48 h. The results showed that PM10 exposure induced an increase in F-actin stress fibers and caused the cytoplasmic stabilization of p21(CIP1/WAF1) via phosphorylation at Thr(145) and Ser(146) and the phosphorylation of ERK1/2 on Thr(202). Changes in the cell cycle or apoptosis were not observed, but an increase in β-galactosidase activity was detected. The PM10 from CZ caused more dramatic effects in lung cells. We conclude that PM10 exposure induced cytoplasmic p21(CIP1/WAF1) retention, ERK1/2 activation, cytoskeleton remodeling and the acquisition of a senescence-like phenotype in lung cells. These alterations could have mechanistic implications regarding the carcinogenic potential of PM10.

Keywords: Cytoskeleton remodeling; PM(10); Particulate matter; Senescence-like; p21(CIP1/WAF1) cytoplasmic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cellular Senescence / drug effects*
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism*
  • Cytoplasm / enzymology
  • Cytoskeleton / drug effects*
  • Cytoskeleton / enzymology
  • Cytoskeleton / pathology
  • Enzyme Activation
  • Humans
  • Lung / drug effects*
  • Lung / enzymology
  • Lung / pathology
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Particle Size
  • Particulate Matter / toxicity*
  • Phenotype
  • Phosphorylation
  • Signal Transduction / drug effects
  • Stress Fibers / drug effects
  • Stress Fibers / enzymology
  • Stress Fibers / pathology
  • Time Factors
  • beta-Galactosidase / metabolism

Substances

  • Actins
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Particulate Matter
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • beta-Galactosidase